637 results on '"Durez, P."'
Search Results
2. Inclusion of fibrinoid necrosis increases the accuracy of synovial tissue assessment in predicting response to methotrexate: analysis of the UCLouvain Brussels ERA Cohort
3. Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial
4. Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study
5. Thermal analysis and efficiency enhancement of solar modified PV panels through organic PCM under climate conditions of Pakistan
6. Should We Use bDMARDs as an Induction Therapy in Early and Severe Rheumatoid Arthritis? Results at 5 years from the ERA UCLouvain Brussels Cohort
7. Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study
8. Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study
9. Should We Use bDMARDs as an Induction Therapy in Early and Severe Rheumatoid Arthritis? Results at 5 years from the ERA UCLouvain Brussels Cohort
10. Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit
11. Modelling and optimization of phase change materials (PCM)-based passive cooling of solar PV panels in multi climate conditions
12. POS0472 RESOLUTION OF SWOLLEN JOINT COUNT IS AN IMPORTANT CLINICAL OBJECTIVE IN EARLY RHEUMATOID ARTHRITIS: ANALYSIS OF THE UCLOUVAIN BRUSSELS ERA COHORT AND COMPARISON WITH THE REMISSION COMPOSITE INDEX
13. OP0165 DIFFICULT TO TREAT RHEUMATOID ARTHRITIS INCIDENCE AND RISK FACTORS IN THE EARLY ARTHRITIS UCLOUVAIN BRUSSELS COHORT
14. POS0476 LUNG INVOLVEMENT IN EARLY RHEUMATOID ARTHRITIS, ANALYSIS OF ERA UCLOUVAIN BRUSSELS FINDRA COHORT
15. AB0611 PREDICTORS OF RA DEVELOPMENT IN PATIENTS WITH ACPA POSITIVE UNDIFFERENTIATED ARTHRITIS: A 2 TO 20 YEARS FOLLOW-UP STUDY OF THE ARTHRITIS UCLOUVAIN BRUSSELS COHORT
16. AB0589 FILGOTINIB IN ACTION: REAL-WORLD INSIGHTS FROM A BELGIAN REGISTRY OF PATIENTS WITH RHEUMATOID ARTHRITIS
17. POS0687 FEASIBILITY, SAFETY, AND APPLICATION FOR CLINICAL INDICATION AND RESEARCH PURPOSES OF SYNOVIAL TISSUE ANALYSIS IN RHEUMATOID ARTHRITIS
18. Should we stop methotrexate or not for vaccination?
19. Anti-TNF Induced Sarcoidosis-Like Disease in Rheumatoid Arthritis Patients: Review Cases from the RA UCLouvain Brussels Cohort
20. Identification of poor prognostic joint locations in an early rheumatoid arthritis cohort at risk of rapidly progressing disease: a post-hoc analysis of the Phase III AGREE study
21. Identification of poor prognostic joint locations in an early rheumatoid arthritis cohort at risk of rapidly progressing disease: a post-hoc analysis of the Phase III AGREE study
22. Editorial: Risk factors for Rheumatoid Arthritis and pre-Rheumatoid Arthritis
23. Rituximab versus tocilizumab and B-cell status in TNF-alpha inadequate-responder rheumatoid arthritis patients: the R4-RA RCT
24. Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies
25. Diagnostic performance of sacroiliac joint MRI and added value of spine MRI to detect active spondyloarthritis
26. SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry
27. Comparative efficacy of subcutaneous (CT-P13) and intravenous infliximab in adult patients with rheumatoid arthritis: a network meta-regression of individual patient data from two randomised trials
28. Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis—a comprehensive review
29. Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study
30. L’hétérogénéité dans la localisation articulaire soutient l’importance des facteurs locaux dans la synovite précoce de la PR : analyse de la cohorte PR UCLouvain Bruxelles
31. Déchiffrer la pneumopathie interstitielle diffuse associée à la polyarthrite rhumatoïde en utilisant une analyse en cluster hiérarchique non supervisée : résultats d’une collaboration internationale
32. Évaluation de la douleur sur 5 ans dans notre cohorte Polyarthrite Rhumatoïde précoce PRp UCLouvain, Bruxelles : résultats et corrélation avec la réponse clinique et la qualité de vie
33. RWD9 Identifying Predictors of Response Following Discontinuation of JAKi Therapy in Patients with Rheumatoid Arthritis
34. La résolution du nombre d’articulations gonflées est un objectif clinique important au début de la polyarthrite rhumatoïde : analyse de la cohorte ERA de l’UCLouvain Bruxelles et comparaison avec l’indice composite de rémission
35. CD68 et la nécrose fibrinoïde sont des biomarqueurs synoviaux de la sévérité de la polyarthrite rhumatoïde précoce et sont associés à une meilleure réponse au méthotrexate : analyse de la cohorte PR-précoce de l’UCLouvain Bruxelles
36. Tapering of biological antirheumatic drugs in rheumatoid arthritis patients is achievable and cost-effective in daily clinical practice: data from the Brussels UCLouvain RA Cohort
37. Glycosylation deficiency of lipopolysaccharide-binding protein and corticosteroid-binding globulin associated with activity and response to treatment for rheumatoid arthritis
38. MRI of Hands with Early Rheumatoid Arthritis: Usefulness of Three-Point Dixon Sequences to Quantitatively Assess Disease Activity
39. Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis—a comprehensive review
40. Comparative efficacy of subcutaneous (CT-P13) and intravenous infliximab in adult patients with rheumatoid arthritis: a network meta-regression of individual patient data from two randomised trials
41. Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis
42. A Cross-Sectional and Longitudinal Study to Define Alarmins and A-SAA Variants as Companion Markers in Early Rheumatoid Arthritis
43. Common Transcriptomic Effects of Abatacept and Other DMARDs on Rheumatoid Arthritis Synovial Tissue
44. Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit
45. Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups
46. Paired Rheumatoid Arthritis Synovial Biopsies From Small and Large Joints Show Similar Global Transcriptomic Patterns With Enrichment of Private Specificity TCRB and TCR Signaling Pathways
47. Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities
48. El intervencionismo militar de Francia en África: una europeización limitada (1960-2019)
49. La diplomatie française et la Francophonie : entre intérêts du pré carré africain et politique québécoise (1964-1970)
50. Fasciae of the musculoskeletal system: normal anatomy and MR patterns of involvement in autoimmune diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.